Invention Grant
- Patent Title: Combination therapy for treating cancer
-
Application No.: US15248080Application Date: 2016-08-26
-
Publication No.: US10525074B2Publication Date: 2020-01-07
- Inventor: Christine Klaus , Maria Alejandra Raimondi , Scott R. Daigle , Roy MacFarlane Pollock
- Applicant: Epizyme, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Epizyme, Inc.
- Current Assignee: Epizyme, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Agent Heidi A. Erlacher; Xixi Sun
- Main IPC: A61K31/7076
- IPC: A61K31/7076 ; A61K31/704 ; A61K31/706 ; A61K31/7068 ; A61K31/4745 ; A61K31/135 ; A61K31/5377 ; A61K31/136 ; A61K31/635
Abstract:
The present invention relates to compositions comprising inhibitors of human histone methyltransferase DOT1L and one or more therapeutic agents, particularly anticancer agents, and methods of combination therapy for administering to subjects in need thereof for the treatment of cancer.
Public/Granted literature
- US20170080010A1 COMBINATION THERAPY FOR TREATING CANCER Public/Granted day:2017-03-23
Information query
IPC分类:
